{
    "title": "Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8730983/Neurocrine-launches-Parkinsons-therapy-COVID-19-related-disruptions-ease.html",
    "date": "2020-09-14",
    "keywords": [
        "drug",
        "supply",
        "dania",
        "nadeem",
        "approval",
        "covid19",
        "time",
        "gorman",
        "neurocrine",
        "monday",
        "addon",
        "treatment",
        "food",
        "roll",
        "executive",
        "officer",
        "hiccup",
        "chain",
        "covid",
        "point",
        "delayed",
        "launch",
        "business",
        "health",
        "spreading",
        "virus",
        "issue",
        "partner",
        "portela",
        "amp",
        "ongentys",
        "effect",
        "levodopa",
        "standard",
        "care",
        "disease",
        "effectiveness",
        "movement",
        "june",
        "fda",
        "april",
        "price",
        "range",
        "market",
        "month",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}